Amedra Pharmaceuticals

Amedra Pharmaceuticals was a specialty pharmaceutical company focused on the development and commercialization of niche brands and generic drug products. The company was best known for its epinephrine auto-injector products, Adrenaclick and Twinject, which are used for the emergency treatment of severe allergic reactions. Additionally, Amedra marketed Albenza (albendazole) for the treatment of parasitic infections and previously held the rights to Daraprim (pyrimethamine). In 2014, the company was acquired by Amneal Pharmaceuticals, which integrated Amedra's portfolio into its specialty business segment. The acquisition allowed Amneal to significantly expand its presence in the high-value specialty drug and delivery device markets.